SCHEMBL10479219

SCHEMBL10479219

C[Si](C)(C)CCCOCn1cc(F)c(=O)[nH]c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
GRIA1 P42261 1/20 0.41
GRIA2 P42262 1/20 0.41
GRIA3 P42263 1/20 0.41
GRIA4 P48058 1/20 0.41
GRIK5 Q16478 1/20 0.41
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPK3 P27361 1/20 0.37
ASAH1 Q13510 1/20 0.37
SQOR Q9Y6N5 1/20 0.37
UPP1 Q16831 1/20 0.37
CA12 O43570 5/20 0.37
CA9 Q16790 5/20 0.37
DUT P33316 1/20 0.36
ESR1 P03372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10479183 0.95 LMNA (0.40) LMNAKMT2ASMN1; SMN2KDM4ECYP1A2
SCHEMBL10479252 0.92 LMNA (0.44) LMNAKMT2ASMN1; SMN2KDM4ECYP1A2
SCHEMBL11399957 0.83 SMN1; SMN2 (0.52) LMNAKMT2ASMN1; SMN2KDM4ECYP1A2
SCHEMBL11397970 0.82 SMN1; SMN2 (0.51) LMNAKMT2ASMN1; SMN2KDM4ECYP1A2
SCHEMBL13650209 0.81 LMNA (0.50) LMNAKMT2ASMN1; SMN2KDM4ECYP1A2
SCHEMBL5017332 0.79 LMNA (0.49) LMNAKMT2ASMN1; SMN2KDM4ECYP1A2
SCHEMBL3786418 0.78 UPP1 (0.57) LMNAKMT2AKDM4ECYP1A2GRIA1
SCHEMBL5015576 0.77 LMNA (0.48) LMNAKMT2ASMN1; SMN2KDM4ECYP1A2
SCHEMBL9596932 0.77 DUT (0.63) LMNAKMT2ASMN1; SMN2KDM4ECYP1A2
SCHEMBL6372044 0.77 LMNA (0.56) LMNAKMT2ASMN1; SMN2KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4868189-A ANTICANCER AGENTS SANWA KAGAKU KENKYUSHO CO. (JP) 1989-09-19 US claimed
EP-0280841-A2 Organo-silicone compounds and use thereof SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1988-09-07 EP claimed
US-4868189-A ANTICANCER AGENTS SANWA KAGAKU KENKYUSHO CO. (JP) 1989-09-19 US disclosed
EP-0280841-A2 Organo-silicone compounds and use thereof SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1988-09-07 EP disclosed